This upregulation may help compensate for the mutants associated with EBS (commonly involving mutations in Krt5 [type II keratin] and Krt14 [type I keratin]) in mouse models, highlighting the functional redundancy within the keratin family as a key factor in modulating the severity of phenotypes[74–76]. The gene discussed is KRT80; the disease is epidermolysis bullosa simplex.